Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

Amani H. Yamani; Basem M. Alraddadi; Reem S. Almaghrabi; Afnan A. Amer; Fatimah S. Mehdawi; Mohammed A AL‐Hamzi; Meshari S. Aldajani; Majda S. Alattas; Aiman M. Elsaed Ramadan; Ghassan Y Wali; Abeer N. Alshukairi; Abbas Al Mutair

doi:10.1002/iid3.587

Loading next page...

References (52)

N. Biran, A. Ip, Jaeil Ahn, Ronaldo Go, Shuqi Wang, S. Mathura, Brittany Sinclaire, Urszula Bednarz, Michael Marafelias, E. Hansen, D. Siegel, A. Goy, A. Pecora, I. Sawczuk, L. Koniaris, Micky Simwenyi, D. Varga, Lisa Tank, A. Stein, V. Allusson, G. Lin, W. Oser, Roman Tuma, J. Reichman, L. Brusco, Kim Carpenter, E. Costanzo, V. Vivona, S. Goldberg (2020)
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
The Lancet Rheumatology, 2
( Harris PA , Taylor R , Minor BL , et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.)
Harris PA , Taylor R , Minor BL , et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA , Taylor R , Minor BL , et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208., Harris PA , Taylor R , Minor BL , et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
V. Veiga, J. Prats, Danielle Farias, R. Rosa, L. Dourado, F. Zampieri, F. Machado, R. Lopes, O. Berwanger, L. Azevedo, Á. Avezum, T. Lisboa, S. Rojas, J. Coelho, R. Leite, J. Carvalho, L. Andrade, A. Sandes, M. Pintão, C. Castro, Sueli Santos, Thiago Almeida, A. Costa, O. Gebara, Flávio Freitas, E. Pacheco, D. Machado, Josiane Martin, F. Conceição, S. Siqueira, L. Damiani, L. Ishihara, Daniel Schneider, Denise Souza, A. Cavalcanti, P. Scheinberg (2021)
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
The BMJ, 372
Mohammed Raja, M. Mendoza, Aasith Villavicencio, S. Anjan, John Reynolds, V. Kittipibul, Anmary Fernandez, G. Guerra, J. Camargo, J. Simkins, Michele Morris, L. Abbo, Y. Natori (2020)
COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature
Transplantation Reviews (Orlando, Fla.), 35
S. AlBahrani, J. Al-Tawfiq, A. Alshaer, A. Shilash, Khalid Alswefy, Razan Al-Zayer, A. Abouelela (2021)
A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital
Journal of Epidemiology and Global Health, 11
( Gorbalenya AE , Baker SC , Baric RS , et al. The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5:536‐544. 10.1038/s41564-020-0695-z 32123347)
Gorbalenya AE , Baker SC , Baric RS , et al. The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5:536‐544. 10.1038/s41564-020-0695-z 32123347
Gorbalenya AE , Baker SC , Baric RS , et al. The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5:536‐544. 10.1038/s41564-020-0695-z 32123347, Gorbalenya AE , Baker SC , Baric RS , et al. The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol. 2020;5:536‐544. 10.1038/s41564-020-0695-z 32123347
( Stone JH , Frigault MJ , Serling‐Boyd NJ , et al. Efficacy of tocilizumab in patients hospitalized with Covid‐19. N Engl J Med. 2020;383(24):2333‐2344.33085857)
Stone JH , Frigault MJ , Serling‐Boyd NJ , et al. Efficacy of tocilizumab in patients hospitalized with Covid‐19. N Engl J Med. 2020;383(24):2333‐2344.33085857
Stone JH , Frigault MJ , Serling‐Boyd NJ , et al. Efficacy of tocilizumab in patients hospitalized with Covid‐19. N Engl J Med. 2020;383(24):2333‐2344.33085857, Stone JH , Frigault MJ , Serling‐Boyd NJ , et al. Efficacy of tocilizumab in patients hospitalized with Covid‐19. N Engl J Med. 2020;383(24):2333‐2344.33085857
W. Alhazzani, Faisal Al-Suwaidan, Z. Aseri, A. Mutair, Ghassan Alghamdi, A. Rabaan, M. Algamdi, Ahmed Alohali, A. Asiri, Mohammed Alshahrani, Maha Al-Subaie, Tareq Alayed, Hind Bafaqih, Safug Alkoraisi, Saad Alharthi, F. Alenezi, Ahmed Gahtani, A. Amr, Abbas Shamsan, Z. Duhailib, Awad Al-omari (2020)
The saudi critical care society clinical practice guidelines on the management of COVID-19 patients in the intensive care unit
, 4
T. Ali, A. Al-Ali, Layal Fajji, E. Hammad, A. Nazmi, I. Alahmadi, H. Aleid, Asad Ullah, Y. Shah, D. Broering (2020)
Coronavirus Disease-19: Disease Severity and Outcomes of Solid Organ Transplant Recipients: Different Spectrum of Disease in Different Populations?
Transplantation
( Raja MA , Mendoza MA , Villavicencio A , et al. COVID‐19 in solid organ transplant recipients: a systematic review and meta‐analysis of current literature. Transplant Rev (Orlando). 2021;35(1):100588.33246166)
Raja MA , Mendoza MA , Villavicencio A , et al. COVID‐19 in solid organ transplant recipients: a systematic review and meta‐analysis of current literature. Transplant Rev (Orlando). 2021;35(1):100588.33246166
Raja MA , Mendoza MA , Villavicencio A , et al. COVID‐19 in solid organ transplant recipients: a systematic review and meta‐analysis of current literature. Transplant Rev (Orlando). 2021;35(1):100588.33246166, Raja MA , Mendoza MA , Villavicencio A , et al. COVID‐19 in solid organ transplant recipients: a systematic review and meta‐analysis of current literature. Transplant Rev (Orlando). 2021;35(1):100588.33246166
Marcus Pereira, S. Mohan, David Cohen, S. Husain, G. Dube, Lloyd Ratner, S. Arcasoy, M. Aversa, L. Benvenuto, Darshana Dadhania, Sandip Kapur, L. Dove, Robert Brown, R. Rosenblatt, B. Samstein, N. Uriel, M. Farr, M. Satlin, C. Small, Thomas Walsh, R. Kodiyanplakkal, B. Miko, J. Aaron, D. Tsapepas, J. Emond, E. Verna (2020)
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
American Journal of Transplantation, 20
( World Health Organization . Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance 28 January 2020; 2021. Accessed September 8, 2021. https://apps.who.int/iris/bitstream/handle/10665/330893/WHO-nCoV-Clinical-2020.3-eng.pdf?sequence=1%26isAllowed=y )
World Health Organization . Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance 28 January 2020; 2021. Accessed September 8, 2021. https://apps.who.int/iris/bitstream/handle/10665/330893/WHO-nCoV-Clinical-2020.3-eng.pdf?sequence=1%26isAllowed=y
World Health Organization . Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance 28 January 2020; 2021. Accessed September 8, 2021. https://apps.who.int/iris/bitstream/handle/10665/330893/WHO-nCoV-Clinical-2020.3-eng.pdf?sequence=1%26isAllowed=y , World Health Organization . Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance 28 January 2020; 2021. Accessed September 8, 2021. https://apps.who.int/iris/bitstream/handle/10665/330893/WHO-nCoV-Clinical-2020.3-eng.pdf?sequence=1%26isAllowed=y
Marcus Pereira, M. Aversa, M. Farr, B. Miko, J. Aaron, S. Mohan, D. Cohen, S. Husain, L. Ratner, S. Arcasoy, N. Uriel, Elizabeth Zheng, Alyson Fox, D. Tsapepas, J. Emond, E. Verna (2020)
Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study
American Journal of Transplantation, 20
M. Pérez-Sáez, M. Blasco, Dolores Redondo-Pachón, Pedro Aguilar, T. Bada-Bosch, I. Pérez-Flores, E. Melilli, L. Sánchez-Cámara, M. López-Oliva, C. Canal, A. Shabaka, N. Moncau, P. Martín-Moreno, V. López, R. Hernández-Gallego, Orlando Siverio, C. Galeano, Jordi Reig, Carlos Cabezas, María Rodrigo, Laura Llinàs-Mallol, M. Fernández‐Reyes, Leonidas Vega, L. Pérez-Tamajón, Raquel Santana-Estupiñán, M. Ruiz-Fuentes, G. Tabernero, S. Zárraga, Juan Ruiz, Á. Gutiérrez-Dalmau, A. Mazuecos, E. Sánchez-Álvarez, M. Crespo, J. Pascual, Isabel García-Méndez, L. Pérez-Oller, M. Giorgi (2020)
Use of tocilizumab in kidney transplant recipients with COVID-19
American Journal of Transplantation, 20
( Pérez‐Sáez MJ , Blasco M , Redondo‐Pachón D , et al. Use of tocilizumab in kidney transplant recipients with COVID‐19. Am J Transplant. 2020;20(11):3182‐3190.32654422)
Pérez‐Sáez MJ , Blasco M , Redondo‐Pachón D , et al. Use of tocilizumab in kidney transplant recipients with COVID‐19. Am J Transplant. 2020;20(11):3182‐3190.32654422
Pérez‐Sáez MJ , Blasco M , Redondo‐Pachón D , et al. Use of tocilizumab in kidney transplant recipients with COVID‐19. Am J Transplant. 2020;20(11):3182‐3190.32654422, Pérez‐Sáez MJ , Blasco M , Redondo‐Pachón D , et al. Use of tocilizumab in kidney transplant recipients with COVID‐19. Am J Transplant. 2020;20(11):3182‐3190.32654422
P. Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-rui Si, Yan Zhu, Bei Li, Chao Huang, Hui-Dong Chen, Jing Chen, Yun Luo, Hua Guo, Ren-di Jiang, Mei Liu, Ying Chen, Xurui Shen, Xi Wang, Xiao-Shuang Zheng, Kai Zhao, Quanjiao Chen, F. Dèng, Lin-lin Liu, Bing-Ru Yan, F. Zhan, Yan-Yi Wang, Geng-Fu Xiao, Z. Shí (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Nature, 579
( Somers EC , Eschenauer GA , Troost JP , et al. Tocilizumab for treatment of mechanically ventilated patients with COVID‐19. Clin Infect Dis. 2020 )
Somers EC , Eschenauer GA , Troost JP , et al. Tocilizumab for treatment of mechanically ventilated patients with COVID‐19. Clin Infect Dis. 2020
Somers EC , Eschenauer GA , Troost JP , et al. Tocilizumab for treatment of mechanically ventilated patients with COVID‐19. Clin Infect Dis. 2020 , Somers EC , Eschenauer GA , Troost JP , et al. Tocilizumab for treatment of mechanically ventilated patients with COVID‐19. Clin Infect Dis. 2020
( Veiga VC , Prats J , Farias DLC , et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:n84.33472855)
Veiga VC , Prats J , Farias DLC , et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:n84.33472855
Veiga VC , Prats J , Farias DLC , et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:n84.33472855, Veiga VC , Prats J , Farias DLC , et al. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021;372:n84.33472855
A. Mutair, A. Elhazmi, S. Alhumaid, Gasmelseed Ahmad, A. Rabaan, Mohammed Alghdeer, Hiba Chagla, R. Tirupathi, Amit Sharma, K. Dhama, Khulud Alsalman, Zainab Alalawi, Z. Aljofan, Alya Mutairi, Mohammed Alomari, Mansour Awad, Awad Al-omari (2021)
Examining the Clinical Prognosis of Critically Ill Patients with COVID-19 Admitted to Intensive Care Units: A Nationwide Saudi Study
Medicina, 57
( Salvarani C , Dolci G , Massari M , et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID‐19 pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):24‐31.33080005)
Salvarani C , Dolci G , Massari M , et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID‐19 pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):24‐31.33080005
Salvarani C , Dolci G , Massari M , et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID‐19 pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):24‐31.33080005, Salvarani C , Dolci G , Massari M , et al. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID‐19 pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):24‐31.33080005
Awad Al-omari, Waad Alhuqbani, Abdul Zaidi, Maha Al-Subaie, A. AlHindi, Ahmed Abogosh, Aljwhara Alrasheed, Aya Alsharafi, M. Alhuqbani, Samer Salih, Mogbil Alhedaithy, R. Abdulqawi, A. Ismail, S. Alhumaid, N. Hamdan, F. Saad, F. Olhaye, T. Eltahir, Mohammed Alomari, Maied Alshehery, Aziz Yassiri, J. Al-Tawfiq, A. Mutair (2020)
Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study
Journal of Infection and Public Health, 13
( Kates OS , Haydel BM , Florman SS , et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020 )
Kates OS , Haydel BM , Florman SS , et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020
Kates OS , Haydel BM , Florman SS , et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020 , Kates OS , Haydel BM , Florman SS , et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020
( Teachey DT , Rheingold SR , Maude SL , et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine‐directed therapy. Blood. 2013;121:5154‐5157. 10.1182/blood-2013-02-485623 23678006)
Teachey DT , Rheingold SR , Maude SL , et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine‐directed therapy. Blood. 2013;121:5154‐5157. 10.1182/blood-2013-02-485623 23678006
Teachey DT , Rheingold SR , Maude SL , et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine‐directed therapy. Blood. 2013;121:5154‐5157. 10.1182/blood-2013-02-485623 23678006, Teachey DT , Rheingold SR , Maude SL , et al. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine‐directed therapy. Blood. 2013;121:5154‐5157. 10.1182/blood-2013-02-485623 23678006
( Almoosa Z , Saad M , Qara S , et al. Favipiravir versus standard of care in patients with severe COVID‐19 infections: a retrospective comparative study. J Infect Public Health. 2021;14:1247‐1253.34464921)
Almoosa Z , Saad M , Qara S , et al. Favipiravir versus standard of care in patients with severe COVID‐19 infections: a retrospective comparative study. J Infect Public Health. 2021;14:1247‐1253.34464921
Almoosa Z , Saad M , Qara S , et al. Favipiravir versus standard of care in patients with severe COVID‐19 infections: a retrospective comparative study. J Infect Public Health. 2021;14:1247‐1253.34464921, Almoosa Z , Saad M , Qara S , et al. Favipiravir versus standard of care in patients with severe COVID‐19 infections: a retrospective comparative study. J Infect Public Health. 2021;14:1247‐1253.34464921
( Zhou P , Yang XL , Wang XG , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. 10.1038/s41586-020-2012-7 32015507)
Zhou P , Yang XL , Wang XG , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. 10.1038/s41586-020-2012-7 32015507
Zhou P , Yang XL , Wang XG , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. 10.1038/s41586-020-2012-7 32015507, Zhou P , Yang XL , Wang XG , et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270‐273. 10.1038/s41586-020-2012-7 32015507
E. Somers, G. Eschenauer, J. Troost, J. Golob, Tejal Gandhi, Lu Wang, Nina Zhou, Lindsay Petty, J. Baang, Nicholas Dillman, D. Frame, K. Gregg, D. Kaul, J. Nagel, T. Patel, Shiwei Zhou, A. Lauring, D. Hanauer, E. Martin, Pratima Sharma, C. Fung, J. Pogue (2020)
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 73
(2016)
Maude SL, Teachey DT, Porter DL, Grupp SA. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015;125(26):4017-4023.
Blood, 128 10
( Guaraldi G , Meschiari M , Cozzi‐Lepri A , et al. Tocilizumab in patients with severe COVID‐19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474‐e484.32835257)
Guaraldi G , Meschiari M , Cozzi‐Lepri A , et al. Tocilizumab in patients with severe COVID‐19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474‐e484.32835257
Guaraldi G , Meschiari M , Cozzi‐Lepri A , et al. Tocilizumab in patients with severe COVID‐19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474‐e484.32835257, Guaraldi G , Meschiari M , Cozzi‐Lepri A , et al. Tocilizumab in patients with severe COVID‐19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474‐e484.32835257
O. Kates, B. Haydel, S. Florman, M. Rana, Z. Chaudhry, M. Ramesh, K. Safa, C. Kotton, E. Blumberg, B. Besharatian, S. Tanna, M. Ison, M. Malinis, M. Azar, R. Rakita, J. Morillas, A. Majeed, A. Sait, M. Spaggiari, V. Hemmige, S. Mehta, H. Neumann, A. Badami, J. Goldman, A. Lala, M. Hemmersbach-Miller, Margaret McCort, Valida Bajrovic, C. Ortiz-Bautista, Rachel Friedman-Moraco, S. Sehgal, E. Lease, C. Fisher, A. Limaye (2020)
COVID-19 in solid organ transplant: A multi-center cohort study
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
( Ali T , Al‐Ali A , Fajji L , et al. Coronavirus disease‐19: disease severity and outcomes of solid organ transplant recipients: different spectrums of disease in different populations? Transplantation. 2021;105(1):121‐127.32852405)
Ali T , Al‐Ali A , Fajji L , et al. Coronavirus disease‐19: disease severity and outcomes of solid organ transplant recipients: different spectrums of disease in different populations? Transplantation. 2021;105(1):121‐127.32852405
Ali T , Al‐Ali A , Fajji L , et al. Coronavirus disease‐19: disease severity and outcomes of solid organ transplant recipients: different spectrums of disease in different populations? Transplantation. 2021;105(1):121‐127.32852405, Ali T , Al‐Ali A , Fajji L , et al. Coronavirus disease‐19: disease severity and outcomes of solid organ transplant recipients: different spectrums of disease in different populations? Transplantation. 2021;105(1):121‐127.32852405
Alexander H, A. Gorbalenya, S. Baker, R. Baric, R. Groot, C. Drosten, A. Gulyaeva, B. Haagmans, C. Lauber, A. Leontovich, B. Neuman, Dmitry Penzar, S. Perlman, L. Poon, Dmitry Samborskiy, I. Sidorov, I. Sola, J. Ziebuhr (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Nature Microbiology, 5
( AlBahrani S , Al‐Tawfiq JA , Alshaer AR , et al. A case series of severe hospitalized COVID‐19 patients treated with tocilizumab and glucocorticoids: a report from Saudi Arabian hospital. J Epidemiol Glob Health. 2021;11:233‐237. 10.2991/jegh.k.210112.001 33605118)
AlBahrani S , Al‐Tawfiq JA , Alshaer AR , et al. A case series of severe hospitalized COVID‐19 patients treated with tocilizumab and glucocorticoids: a report from Saudi Arabian hospital. J Epidemiol Glob Health. 2021;11:233‐237. 10.2991/jegh.k.210112.001 33605118
AlBahrani S , Al‐Tawfiq JA , Alshaer AR , et al. A case series of severe hospitalized COVID‐19 patients treated with tocilizumab and glucocorticoids: a report from Saudi Arabian hospital. J Epidemiol Glob Health. 2021;11:233‐237. 10.2991/jegh.k.210112.001 33605118, AlBahrani S , Al‐Tawfiq JA , Alshaer AR , et al. A case series of severe hospitalized COVID‐19 patients treated with tocilizumab and glucocorticoids: a report from Saudi Arabian hospital. J Epidemiol Glob Health. 2021;11:233‐237. 10.2991/jegh.k.210112.001 33605118
( Galván‐Román JM , Rodríguez‐García SC , Roy‐Vallejo E , et al. IL‐6 serum levels predict severity and response to tocilizumab in COVID‐19: an observational study. J Allergy Clin Immunol. 2021;147(1):72‐80e78.33010257)
Galván‐Román JM , Rodríguez‐García SC , Roy‐Vallejo E , et al. IL‐6 serum levels predict severity and response to tocilizumab in COVID‐19: an observational study. J Allergy Clin Immunol. 2021;147(1):72‐80e78.33010257
Galván‐Román JM , Rodríguez‐García SC , Roy‐Vallejo E , et al. IL‐6 serum levels predict severity and response to tocilizumab in COVID‐19: an observational study. J Allergy Clin Immunol. 2021;147(1):72‐80e78.33010257, Galván‐Román JM , Rodríguez‐García SC , Roy‐Vallejo E , et al. IL‐6 serum levels predict severity and response to tocilizumab in COVID‐19: an observational study. J Allergy Clin Immunol. 2021;147(1):72‐80e78.33010257
A. Mutair, S. Alhumaid, Waad Alhuqbani, Abdul Zaidi, Safug Alkoraisi, Maha Al-Subaie, A. AlHindi, Ahmed Abogosh, Aljwhara Alrasheed, Aya Alsharafi, M. Alhuqbani, N. Alhowar, Samer Salih, Mogbil Alhedaithy, J. Al-Tawfiq, Haifa Al-Shammari, R. Abdulqawi, A. Ismail, N. Hamdan, F. Saad, F. Olhaye, T. Eltahir, A. Rabaan, Awad Al-omari (2020)
Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study
European Journal of Medical Research, 25
( Al Mutair A , Al Mutairi A , Zaidi ARZ , et al. Clinical predictors of COVID‐19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719‐3728.34321917)
Al Mutair A , Al Mutairi A , Zaidi ARZ , et al. Clinical predictors of COVID‐19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719‐3728.34321917
Al Mutair A , Al Mutairi A , Zaidi ARZ , et al. Clinical predictors of COVID‐19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719‐3728.34321917, Al Mutair A , Al Mutairi A , Zaidi ARZ , et al. Clinical predictors of COVID‐19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719‐3728.34321917
J. Stone, M. Frigault, Naomi Serling-Boyd, Ana Fernandes, Liam Harvey, A. Foulkes, N. Horick, B. Healy, R. Shah, A. Bensaci, A. Woolley, S. Nikiforow, N. Lin, M. Sagar, H. Schrager, D. Huckins, M. Axelrod, M. Pincus, J. Fleisher, C. Sacks, M. Dougan, C. North, Y. Halvorsen, Tara Thurber, Z. Dagher, Allison Scherer, Rachel Wallwork, A. Kim, S. Schoenfeld, Pritha Sen, T. Neilan, C. Perugino, S. Unizony, Deborah Collier, M. Matza, J. Yinh, Kathryn Bowman, Eric Meyerowitz, A. Zafar, Z. Drobni, M. Bolster, M. Kohler, K. D’Silva, J. Dau, M. Lockwood, Caroline Cubbinson, B. Weber, M. Mansour (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
The New England Journal of Medicine
( Biran N , Ip A , Ahn J , et al. Tocilizumab among patients with COVID‐19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;2(10):e603‐e612.32838323)
Biran N , Ip A , Ahn J , et al. Tocilizumab among patients with COVID‐19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;2(10):e603‐e612.32838323
Biran N , Ip A , Ahn J , et al. Tocilizumab among patients with COVID‐19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;2(10):e603‐e612.32838323, Biran N , Ip A , Ahn J , et al. Tocilizumab among patients with COVID‐19 in the intensive care unit: a multicentre observational study. Lancet Rheumatol. 2020;2(10):e603‐e612.32838323
( Roberts MB , Izzy S , Tahir Z , Al Jarrah A , Fishman JA , El Khoury J . COVID‐19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients. Transpl Infect Dis. 2020;22(5):e13407.32654303)
Roberts MB , Izzy S , Tahir Z , Al Jarrah A , Fishman JA , El Khoury J . COVID‐19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients. Transpl Infect Dis. 2020;22(5):e13407.32654303
Roberts MB , Izzy S , Tahir Z , Al Jarrah A , Fishman JA , El Khoury J . COVID‐19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients. Transpl Infect Dis. 2020;22(5):e13407.32654303, Roberts MB , Izzy S , Tahir Z , Al Jarrah A , Fishman JA , El Khoury J . COVID‐19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients. Transpl Infect Dis. 2020;22(5):e13407.32654303
A. Mutair, Alya Mutairi, Abdul Zaidi, Samer Salih, S. Alhumaid, A. Rabaan, Awad Al-omari (2021)
Clinical Predictors of COVID-19 Mortality Among Patients in Intensive Care Units: A Retrospective Study
International Journal of General Medicine, 14
C. Salvarani, G. Dolci, M. Massari, D. Merlo, S. Cavuto, L. Savoldi, P. Bruzzi, F. Boni, L. Braglia, Caterina Turrà, P. Ballerini, R. Sciascia, L. Zammarchi, O. Para, P. Scotton, W. Inojosa, V. Ravagnani, Nicola Salerno, P. Sainaghi, A. Brignone, M. Codeluppi, Elisabetta Teopompi, Maurizio Milesi, P. Bertomoro, Norbiato Claudio, M. Salio, M. Falcone, G. Cenderello, Lorenzo Donghi, V. Bono, P. Colombelli, A. Angheben, A. Passaro, G. Secondo, R. Pascale, I. Piazza, N. Facciolongo, M. Costantini (2020)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA internal medicine
J. Galván-Román, S. Rodriguez-García, E. Roy-Vallejo, A. Marcos-Jiménez, S. Sánchez-Alonso, C. Fernández-Díaz, Ana Alcaraz-Serna, T. Mateu-Albero, Pablo Rodríguez-Cortés, I. Sánchez‐Cerrillo, L. Esparcia, P. Martínez-Fleta, C. López-Sanz, Ligia Gabrie, Luciana Guerola, C. Suárez-Fernández, J. Ancochea, A. Canabal, P. Albert, D. Rodríguez-Serrano, J. Aguilar, C. Arco, I. Santos, Lucio García-Fraile, R. Cámara, J. Serra, E. Ramírez, T. Alonso, P. Landete, J. Soriano, E. Martín-Gayo, A. Torres, N. Cruz, R. García-Vicuña, L. Cardeñoso, F. Sánchez‐Madrid, A. Alfranca, C. Muñoz‐Calleja, I. González-Álvaro, T. Alvarado, P. Martínez, Francisco Llorente, C. Arco, N. Villalba, M. Negro, E. Contreras, A. Rey, C. Santiago, M. Junquera, R. Caminero, F. Val, S. González, M. Cano, Isabel López, Andrés Wernitz, Bárbara Retana, Iñigo Guerra, Jorge Sorando, Lydia Chao, M. Cárdenas, V. Espiga, P. Chicharro, P. Rodríguez, I. Alday, M. Sampedro, J. Prada, E. Aldama, Y. Real, M. Caldas, S. Casabona, Aitor Lanas-Gimeno, R. Camara, A. Alvárez, Beatriz Aguadol, A. Morell, A. Zurriaga, M. Abánades, S. García, T. Aranda, M. Ruiz, C. Nieto, J. Aspa, Luciana Guerola, Elena Fernández, Marelys Calzada, R. Tejedor, J. Iglesias, F. Suarez, Juan Sánchez, B. Abad, C. Suárez, Ignacio Santos, J. Galván-Román, Emilia Roy, J. Sanz, Eduardo Sánchez, F. Moldenhauer, P. Casado, J. Curbelo, Á. Gutiérrez, Azucena Bautista, N. Giménez, Angelica Fernández, P. Parra, Berta Moyano, A. Barrios, D. Asúa, Beatriz Sánchez, C. Sáez, M. Ciudad, D. Navas, L. Domingo, María Torresano, D. García, T. Cavero, A. Blanco, A. Ramírez, María Chong, Ainhoa Cobos, A. Torres, Carmen Sánchez-González, A. Perpén, C. Pérez, J. Soriano, C. Cisneros, Elena Castillo, F. Pérez, R. Girón, C. Marcos, E. Zamora, P. García, S. Castañeda, S. Rodriguez-García, Irene Cubas, E. Tomero, N. Castañeda, A. Ortiz, C. Valero, M. Uriarte, N. Montes (2020)
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
The Journal of Allergy and Clinical Immunology, 147
Z. Almoosa, M. Saad, Samer Qara, M. Mustafa, A. Mansour, Duaa Alshab, Jehad Alhashem, S. Alkhawajah, Saleh Alkhalifah, Mokhtar ALmarzooq, Mohammed Alzain, Neda’aW Anshasi, G. Ahmed, A. Mutair (2021)
Favipiravir versus standard of care in patients with severe COVID-19 infections: A retrospective comparative study
Journal of Infection and Public Health, 14
( Al‐Omari A , Alhuqbani WN , Zaidi ARZ , et al. Clinical characteristics of non‐intensive care unit COVID‐19 patients in Saudi Arabia: a descriptive cross‐sectional study. J Infect Public Health. 2020;13:1639‐1644. 10.1016/j.jiph.2020.09.003 33004305)
Al‐Omari A , Alhuqbani WN , Zaidi ARZ , et al. Clinical characteristics of non‐intensive care unit COVID‐19 patients in Saudi Arabia: a descriptive cross‐sectional study. J Infect Public Health. 2020;13:1639‐1644. 10.1016/j.jiph.2020.09.003 33004305
Al‐Omari A , Alhuqbani WN , Zaidi ARZ , et al. Clinical characteristics of non‐intensive care unit COVID‐19 patients in Saudi Arabia: a descriptive cross‐sectional study. J Infect Public Health. 2020;13:1639‐1644. 10.1016/j.jiph.2020.09.003 33004305, Al‐Omari A , Alhuqbani WN , Zaidi ARZ , et al. Clinical characteristics of non‐intensive care unit COVID‐19 patients in Saudi Arabia: a descriptive cross‐sectional study. J Infect Public Health. 2020;13:1639‐1644. 10.1016/j.jiph.2020.09.003 33004305
DT Teachey, SR Rheingold, SL Maude (2013)
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine‐directed therapy
, 121
G. Guaraldi, Marianna Meschiari, A. Cozzi-Lepri, J. Milic, R. Tonelli, M. Menozzi, E. Franceschini, G. Cuomo, G. Orlando, V. Borghi, A. Santoro, M. Gaetano, C. Puzzolante, F. Carli, A. Bedini, L. Corradi, R. Fantini, I. Castaniere, L. Tabbì, M. Girardis, S. Tedeschi, M. Giannella, M. Bartoletti, R. Pascale, G. Dolci, L. Brugioni, A. Pietrangelo, A. Cossarizza, F. Pea, E. Clini, C. Salvarani, M. Massari, P. Viale, C. Mussini (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
The Lancet Rheumatology, 2
( Pereira MR , Aversa MM , Farr MA , et al. Tocilizumab for severe COVID‐19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020;20(11):3198‐3205.32946668)
Pereira MR , Aversa MM , Farr MA , et al. Tocilizumab for severe COVID‐19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020;20(11):3198‐3205.32946668
Pereira MR , Aversa MM , Farr MA , et al. Tocilizumab for severe COVID‐19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020;20(11):3198‐3205.32946668, Pereira MR , Aversa MM , Farr MA , et al. Tocilizumab for severe COVID‐19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020;20(11):3198‐3205.32946668
( Hermine O , Mariette X , Tharaux PL , et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID‐19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32‐40.33080017)
Hermine O , Mariette X , Tharaux PL , et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID‐19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32‐40.33080017
Hermine O , Mariette X , Tharaux PL , et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID‐19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32‐40.33080017, Hermine O , Mariette X , Tharaux PL , et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID‐19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32‐40.33080017
M. Roberts, Saef Izzy, Zabreen Tahir, Ali Jarrah, J. Fishman, J. Khoury (2020)
COVID‐19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non‐ICU admitted patients
Transplant Infectious Disease, 22
( Alhazzani W , Al‐Suwaidan F , Al Aseri Z , et al. The Saudi critical care society clinical practice guidelines on the management of COVID‐19 patients in the intensive care unit. Saudi Crit Care J. 2020;4:27. 10.4103/sccj.sccj_15_20 )
Alhazzani W , Al‐Suwaidan F , Al Aseri Z , et al. The Saudi critical care society clinical practice guidelines on the management of COVID‐19 patients in the intensive care unit. Saudi Crit Care J. 2020;4:27. 10.4103/sccj.sccj_15_20
Alhazzani W , Al‐Suwaidan F , Al Aseri Z , et al. The Saudi critical care society clinical practice guidelines on the management of COVID‐19 patients in the intensive care unit. Saudi Crit Care J. 2020;4:27. 10.4103/sccj.sccj_15_20 , Alhazzani W , Al‐Suwaidan F , Al Aseri Z , et al. The Saudi critical care society clinical practice guidelines on the management of COVID‐19 patients in the intensive care unit. Saudi Crit Care J. 2020;4:27. 10.4103/sccj.sccj_15_20
O. Hermine, X. Mariette, P. Tharaux, M. Resche-Rigon, R. Porcher, P. Ravaud (2020)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
JAMA internal medicine
Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance
P. Harris, Robert Taylor, Brenda Minor, V. Elliott, Michelle Fernandez, Lindsay O'Neal, Laura McLeod, Giovanni Delacqua, Francesco Delacqua, Jacqueline Kirby, S. Duda (2019)
The REDCap consortium: Building an international community of software platform partners
Journal of biomedical informatics

Publisher: Wiley
eISSN: 2050-4527
DOI: 10.1002/iid3.587
Publisher site: See Article on Publisher Site

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

Early use of tocilizumab in solid organ transplant recipients with COVID‐19: A retrospective cohort study in Saudi Arabia

References (52)

Abstract

Journal

Recommended Articles

There are no references for this article.

Our policy towards the use of cookies